HAVCR2 and glioma: In a preclinical study of mice carrying a murine glioma cell line GL261-luc, Lim reported that the combination therapy of anti-TIM-3 antibody and stereotactic radiosurgery was more effective than anti-TIM-3 antibody alone in the regression of murine gliomas, accompanied with an elevated immune response [232].